Stock Earnings

Question 1

What are 10X Genomics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), 10X Genomics Inc has a total asset of $918, Net loss of $-182

Question 2

What are the key financial ratios for TXG?

Accepted Answer

10X Genomics Inc's Current ratio is 4.41, has a Net margin is -29.83, sales per share of $5.06.

Question 3

How is 10X Genomics Inc's revenue broken down by segment or geography?

Accepted Answer

10X Genomics Inc largest revenue segment is Total Instruments, at a revenue of 40,128,000 in the most earnings release.For geography, Europe, Middle East and Africa is the primary market for 10X Genomics Inc, at a revenue of 159,762,000.

Question 4

Is 10X Genomics Inc profitable?

Accepted Answer

no, according to the latest financial statements, 10X Genomics Inc has a net loss of $-182

Question 5

Does 10X Genomics Inc have any liabilities?

Accepted Answer

yes, 10X Genomics Inc has liability of 208

Question 6

How many outstanding shares for 10X Genomics Inc?

Accepted Answer

10X Genomics Inc has a total outstanding shares of 122.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	641	610	618	516	490	298
Revenue Growth (YoY)	2%	-1%	20%	5%	64%	22%
Cost of Revenue	199	196	209	120	74	58
Gross Profit	442	414	409	396	416	240
Selling, General & Admin	330	343	336	298	257	199
Research & Development	245	263	268	265	211	570
Operating Expenses	576	607	604	564	468	771
Other Non Operating Income (Expenses)	1	-1	1	0	0	1
Pretax Income	-73	-177	-248	-162	-53	-534
Income Tax Expense	3	4	6	4	4	8
Net Income	-76	-182	-255	-166	-58	-542
Net Income Growth	-57.99%	-28.99%	54%	186%	-89%	1,648%
Shares Outstanding (Diluted)	125.5	120.45	117.16	113.9	110.3	101.2
Shares Change (YoY)	4%	3%	3%	3%	9%	5%
EPS (Diluted)	-0.62	-1.51	-2.17	-1.46	-0.53	-5.37
EPS Growth	-59%	-30%	49%	175%	-90%	1,578%
Free Cash Flow	81	-6	-64	-165	-122	-256
Free Cash Flow Per Share	0.64	-0.04	-0.54	-1.44	-1.1	-2.52
Gross Margin	68.95%	67.86%	66.18%	76.74%	84.89%	80.53%
Operating Margin	-20.9%	-31.47%	-31.39%	-32.36%	-10.61%	-178.18%
Profit Margin	-11.85%	-29.83%	-41.26%	-32.17%	-11.83%	-181.87%
Free Cash Flow Margin	12.63%	-0.98%	-10.35%	-31.97%	-24.89%	-85.9%
EBITDA	-106	-157	-159	-142	-31	-517
EBITDA Margin	-16.53%	-25.73%	-25.72%	-27.51%	-6.32%	-173.48%
D&A For EBITDA	28	35	35	25	21	14
EBIT	-134	-192	-194	-167	-52	-531
EBIT Margin	-20.9%	-31.47%	-31.39%	-32.36%	-10.61%	-178.18%
Effective Tax Rate	-4.1%	-2.25%	-2.41%	-2.46%	-7.54%	-1.49%

10X Genomics Inc (TXG) Price

TXG Stock Price Chart

TXG Income

Follow-Up Questions